A recent study has developed nanovesicles (NVs) from activated neutrophils, showcasing their ability to perform molecular debridement and accelerate healing in infectious wounds. This novel method significantly enhances treatment effectiveness, particularly for stubborn diabetic wounds, by targeting and neutralizing deep tissue pathogens.
Chula Medicine in collaboration with the Department of Thai Traditional and Alternative Medicine and Gastroenterologists from Thai medical schools proves that Thai curcumin can help treat dyspepsia as effectively as antacids. The research is poised to push Thai curcumin to the global marketplace.
A multi-institutional study found that 1 in 6 youths fill an opioid prescription prior to surgery, and 3% of patients were still filling opioid prescriptions three to six months after surgery, indicating persistent opioid use and possible opioid dependence.
Researchers have developed a simple new way to store, identify, and share phages, making them more accessible to clinicians trying to save patients with antimicrobial-resistant superbugs.
Research published in Science Translational Medicine advances therapies to regenerate beta cells as a potential new treatment for diabetes
Weight-loss drugs are all over the news these days. A Penn State Health expert helps separate fact from fiction and determine what’s the safest alterative for the people who need them.
Mount Sinai study suggests adhering to FDA-regulated expiration dates could prevent this
New research led by UCLA Health has found a drug that treats insomnia works to prevent the addictive effects of the morphine opioids in mice while still providing effective pain relief.
A new study suggests patients taking semaglutide — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an eye condition that can cause blindness.
In 2016, nearly 2 million opioid prescriptions were given to patients across the state. However, by the end of the study period in 2020, there was a 38 percent decrease in opioid prescriptions written, according to this study by Dr. Asif Ilyas.
Researchers at University of California San Diego show that a molecule which shuttles damaging inflammatory cells into cancer tumors also shuttles inflammatory cells into lung tissue infected with COVID-19 — and that the molecule can be suppressed with a repurposed cancer drug. The work represents a new approach to preventing irreversible organ damage in infectious diseases.
Scientists from Immanuel Kant Baltic Federal University found out that polymeric coating enables to improve the structure and properties of magnetoelectric composites, that are used in medicine for drug delivery and also in creation of implants and tissues. Thus, modification with polymer helps equal distribution of composite’s components, and also enhances its piezoelectric properties by 40%.
A pivotal study has demystified the genetic underpinnings of schaftoside, a vital compound in traditional Chinese medicine (TCM) with significant potential as a COVID-19 therapeutic. The research decodes the biosynthetic pathway and uncovers gene expansions within the Grona styracifolia genome, providing critical insights for optimizing the production of this promising medicinal agent.
Drugs that selectively kill senescent cells may benefit otherwise healthy older women but are not a "one-size-fits-all" remedy, Mayo Clinic researchers have found. Specifically, these drugs may only benefit people with a high number of senescent cells, according to findings publishing July 2 in Nature Medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
